Group 1 - The core point of the article is that Kexing Pharmaceutical-B has been actively repurchasing its shares, with a total of 382.55 million shares repurchased this year, amounting to 607.28 million HKD [2][3] - On November 21, the company repurchased 235,000 shares at a price range of 16.570 to 17.090 HKD, totaling 3.9829 million HKD, while the stock closed at 16.920 HKD, down 4.14% for the day [2] - Since November 20, the company has conducted share buybacks for two consecutive days, repurchasing a total of 403,000 shares for a cumulative amount of 6.9572 million HKD, during which the stock price has decreased by 2.25% [2][3] Group 2 - The detailed buyback history shows that on November 20, 168,000 shares were repurchased at a maximum price of 17.850 HKD and a minimum price of 17.540 HKD, totaling 2.9744 million HKD [3] - The largest buyback occurred on November 6, with 1.734 million shares repurchased at a maximum price of 15.800 HKD, totaling 26.3078 million HKD [3] - The buyback activity indicates a strategic move by the company to support its stock price amid recent declines [2][3]
科济药业-B(02171.HK)11月21日回购23.50万股，耗资398.29万港元